Impacts of Biosimilars

Impacting the entire health care system

We’re committed to the development of biosimilars because of the additional treatment options they provide to patients and the positive impact they can have on the entire health care system.

At a time when health care costs are rising, we aspire to contribute to a more sustainable health care system by providing more options and cost savings through our biosimilar medicines.

Impacting each and every patient

At the heart of Amgen’s commitment to biosimilars is our mission to serve patients. Quality, reliably supplied biosimilars are anticipated to offer more treatment options for patients—and we believe that we bring high-quality science to this new space in health care.

We want to help patients access the medicines they need. With increased availability of lower-cost biosimilars, it should be easier to choose the right medicine at the right time.

Next: Therapeutic Area Commitment

Previous: Significant Investments